Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multiple sclerosis--update].

H P Mattle1

  • 1Neurologische Klinik und Poliklinik der Universität, Inselspital, Bern. heinrich.mattle@insel.ch

Praxis
|August 25, 2005
PubMed
Summary
This summary is machine-generated.

Multiple sclerosis (MS) is a chronic central nervous system inflammatory disease. Treatments include corticosteroids for relapses and immunomodulation for reducing relapse severity and long-term disability.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of intravenous thrombolysis on recanalization rates in patients with stroke treated with bridging therapy.

European journal of neurology·2017
Same author

Impact of Anesthesia on the Outcome of Acute Ischemic Stroke after Endovascular Treatment with the Solitaire Stent Retriever.

AJNR. American journal of neuroradiology·2017
Same author

Whole-Brain Susceptibility-Weighted Thrombus Imaging in Stroke: Fragmented Thrombi Predict Worse Outcome.

AJNR. American journal of neuroradiology·2015
Same author

Thrombolysis in patients with prior stroke within the last 3 months.

European journal of neurology·2014
Same author

Passing the thrombus in endovascular treatment of acute ischemic stroke: do we penetrate the thrombus?

The neuroradiology journal·2013
Same author

Endovascular therapy in 201 patients with acute symptomatic occlusion of the internal carotid artery.

European journal of neurology·2013
Same journal

Praxis·2026
Same journal

[What do Swiss doctors think about cardiovascular risk factors and guidelines?]

Praxis·2026
Same journal

[Laser interstitial thermotherapy (LITT): a minimally invasive neurosurgical treatment option for brain tumours and radiation necrosis].

Praxis·2026
Same journal

[Persistent back pain after lifting trauma. From the trivial to the rare case].

Praxis·2026
Same journal

[A patient with dizziness and gait instability - a diagnostic challenge].

Praxis·2026
Same journal

[Meningoencephalitis caused by listeria monocytogenes].

Praxis·2026
See all related articles

Area of Science:

  • Neurology
  • Immunology
  • Pathology

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
  • Auto-reactive T-cells and monocytes are key pathogenetic players.
  • Inflammation leads to demyelination, axonal loss, and neuronal damage.

Purpose of the Study:

  • To summarize the pathophysiology, clinical presentation, diagnosis, and treatment of multiple sclerosis.
  • To highlight the role of immune cells in MS pathogenesis.
  • To outline current therapeutic strategies for managing MS.

Main Methods:

  • Review of the pathophysiology of multiple sclerosis.
  • Description of clinical symptoms and diagnostic findings.
  • Summary of current treatment modalities.

Related Experiment Videos

Main Results:

  • MS presents with diverse neurological deficits, including visual disturbances, sensory and motor weakness, cognitive impairment, and bladder dysfunction.
  • Diagnosis is supported by MRI findings, cerebrospinal fluid analysis (oligoclonal bands), and evoked potentials.
  • Treatment strategies vary from corticosteroids for relapses to immunomodulation and immunosuppression for managing disease progression and severity.

Conclusions:

  • MS is a complex autoimmune disease requiring a multifaceted approach to management.
  • Early diagnosis and appropriate treatment can mitigate relapse frequency and slow long-term disability.
  • Ongoing research aims to further elucidate MS etiology and develop more effective therapies.